フローサイトメトリー市場:技術(セルベース、ビーズベース)、製品・サービス(アナライザー、ソーター、消耗品、ソフトウェア)、アプリケーション((研究-免疫学、幹細胞)、(臨床-血液学))、エンドユーザー(バイオテクノロジー、病院)-2027年までの世界市場予測Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application ((Research - Immunology, Stem cell), (Clinical - Hematology)), End user (Biotech, Hospitals) - Global Forecast to 2027 フローサイトメトリーの世界市場は、2022年の47億ドルから2027年には69億ドルに達すると予測され、予測期間中のCAGRは8.1%である。HIV/AIDS、癌、自己免疫疾患の世界的な流行が、診断のためのフローサイトメトリ... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーフローサイトメトリーの世界市場は、2022年の47億ドルから2027年には69億ドルに達すると予測され、予測期間中のCAGRは8.1%である。HIV/AIDS、癌、自己免疫疾患の世界的な流行が、診断のためのフローサイトメトリーの採用を増加させ、市場成長を予測しています。さらに、技術的に進化した製品の発売が、2022-2027年の予測期間中に市場成長を促進する可能性があります。"2021年のフローサイトメトリー世界市場では、インストルメント部門がかなりのシェアを占めました。" 製品・サービスに基づいて、市場は試薬・消耗品、機器、サービス、ソフトウェア、アクセサリーに区分されます。試薬&消耗品セグメントは2021年の市場で圧倒的なシェアを占め、予測期間中も優位性を保つと予測されます。研究をより速いペースで成長させる新しい試薬&消耗品の市場投入は、セグメント成長を促進すると思われる。2021年11月、Bio-Rad Laboratories, Inc.(米国)は、フローサイトメトリーアプリケーションでUVレーザーを使用するために設計された蛍光ナノ粒子「StarBright UltraViolet 400 Dye」を発売しました。 "2021年、研究用途セグメントが市場を独占" エンドユーザーに基づいて、フローサイトメトリー市場は、研究アプリケーション、臨床アプリケーション、産業アプリケーションに区分されます。フローサイトメトリーの臨床アプリケーションにおける主要な市場プレイヤーの強い注力は、セグメントの成長を予測するものと思われます。2021年10月、BD(Becton, Dickinson and Company)(米国)は、Christian Medical College Vellore(インド)と共同で、インドにおける臨床研究のためのフローサイトメトリーにおける2番目のCoE(Center of Excellence)を立ち上げた。 "2021年、北米が圧倒的なシェアを占める" フローサイトメトリー市場は、地域的には、北米、欧州、アジア太平洋、中南米、中東・アフリカに区分されます。2021年のフローサイトメトリー市場は、北米が主要シェアを占めています。北米は、主要な市場プレイヤーの存在と、同地域における研究アプリケーションでのフローサイトメトリー採用の増加により、支配的なシェアを占めた。アジア太平洋地域は、研究資金の増加や臨床アプリケーションでのフローサイトメトリーの採用により、より速いペースで成長すると予想される。 本レポートのために実施した一次インタビューは、以下のように分類される。 - 企業タイプ別 - サプライサイド: 70.0%, デマンドサイド: 30.0 - 役職別 - マネージャー: 45.0%, CXO & ディレクター: 30.0%, 経営幹部: 25.0 - 地域別:北米20%、欧州10%、アジア太平洋55%、中南米10%、中東・アフリカ5 報告書に掲載された企業一覧 o ベクトン・ディッキンソン・アンド・カンパニー(米国) o ダナハーコーポレーション(米国) o サーモフィッシャーサイエンティフィック(米国) ルミネックスコーポレーション(米国) o アジレント・テクノロジー株式会社(米国) ソニーグループ (日本) バイオ・ラッド・ラボラトリーズ(米国) ミルテニ・バイオテック社(ドイツ) エンゾ・バイオケム社(米国) シスメックス株式会社(日本) bioMérieux S.A.(フランス) o Cytonome/ST、LLC(米国) o サルトリウスAG(ドイツ) o サイテック・バイオサイエンシズ株式会社(米国) ユニオン・バイオメトリカ(米国) アポジー フローシステムズ社(英国(英国) o Stratedigm, Inc.(米国) ナノセレクトバイオメディカル(米国) o オンチップ・バイオテクノロジーズ(株(日本) o BennuBio Inc.(米国) o ORFLO Technologies(米国) o Bay Biosciences Co.(日本) o BioLegend, Inc.(米国) o CytoBuoy B.V (オランダ). 調査対象範囲 本レポートは、世界のフローサイトメトリー市場の詳細な情報を提供します。技術、製品・サービス、アプリケーション、エンドユーザー、地域など、さまざまなセグメントにおける市場規模と今後の成長性を推定することを目的としています。また、市場成長に影響を与える要因(ドライバー、阻害要因、機会など)を分析しています。利害関係者向けに市場の機会を評価し、市場リーダー向けに競争環境の詳細を提供しています。また、マイクロマーケットについて、その成長動向、展望、フローサイトメトリー市場全体への貢献度に関しても調査しています。本レポートでは、4つの主要地域に関して、市場セグメントの収益を予測しています。 レポートを購入する理由 本レポートは、以下のポイントに関する洞察を提供しています。 - 市場の浸透。フローサイトメトリー市場の上位25社が提供する細胞分析に関する包括的な情報。フローサイトメトリー市場を技術、製品&サービス、アプリケーション、エンドユーザー、地域別に分析しています。 - 市場開発。有利な新興市場に関する包括的な情報です。本レポートでは、主要な地域ごとの各種フローサイトメトリー製品の市場について分析しています。 - 市場の多様化。フローサイトメトリー市場における新製品、未開拓の地域、最近の開発、投資に関する情報を網羅的に提供します。 - 競争力の評価。フローサイトメトリー市場における主要企業の市場ランキングと戦略に関する詳細な評価。 目次1 INTRODUCTION 431.1 STUDY OBJECTIVES 43 1.2 MARKET DEFINITION 43 1.2.1 INCLUSIONS & EXCLUSIONS 44 1.3 STUDY SCOPE 44 1.3.1 MARKETS COVERED 44 1.3.2 YEARS CONSIDERED 45 1.4 CURRENCY CONSIDERED 45 1.5 LIMITATIONS 45 1.6 STAKEHOLDERS 46 1.7 SUMMARY OF CHANGES 46 2 RESEARCH METHODOLOGY 48 2.1 RESEARCH DATA 48 FIGURE 1 RESEARCH DESIGN 48 2.1.1 SECONDARY DATA 49 2.1.2 PRIMARY DATA 50 FIGURE 2 FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES 50 2.2 MARKET ESTIMATION METHODOLOGY 51 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 51 FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 52 FIGURE 4 AVERAGE MARKET SIZE ESTIMATION (2021) 52 2.3 DATA TRIANGULATION APPROACH 54 FIGURE 5 DATA TRIANGULATION METHODOLOGY 54 2.4 GROWTH FORECAST 55 2.5 LIMITATIONS 55 2.6 RISK ASSESSMENT 55 2.7 CAGR PROJECTIONS 56 2.7.1 SUPPLY-SIDE ANALYSIS 56 2.7.2 DEMAND-SIDE ANALYSIS 56 2.7.3 INSIGHTS FROM PRIMARY EXPERTS 57 3 EXECUTIVE SUMMARY 58 FIGURE 6 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION) 58 FIGURE 7 FLOW CYTOMETRY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 59 FIGURE 8 FLOW CYTOMETRY MARKET, BY END USER, 2021 59 FIGURE 9 GEOGRAPHICAL SNAPSHOT 60 4 PREMIUM INSIGHTS 61 4.1 FLOW CYTOMETRY MARKET OVERVIEW 61 FIGURE 10 INCREASING PREVALENCE OF AUTOIMMUNE DISEASES AND RISING ADVANCEMENTS IN FLOW CYTOMETRY TECHNIQUES DRIVE MARKET GROWTH 61 4.2 ASIA PACIFIC: FLOW CYTOMETRY MARKET SHARE, BY PRODUCT & SERVICE (2021) 62 FIGURE 11 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2021 62 4.3 FLOW CYTOMETRY MARKET SHARE, BY TECHNOLOGY, 2022 VS. 2027 63 FIGURE 12 CELL-BASED FLOW CYTOMETRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 63 4.4 FLOW CYTOMETRY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 64 FIGURE 13 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 64 5 MARKET OVERVIEW 65 5.1 INTRODUCTION 65 5.2 MARKET DYNAMICS 65 FIGURE 14 FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65 5.2.1 DRIVERS 66 5.2.1.1 Increasing incidence of HIV/AIDS and cancer 66 TABLE 1 INCIDENCE OF HIV/AIDS, BY REGION, 2020 66 TABLE 2 CANCER INCIDENCE, 2020 VS. 2040 66 5.2.1.2 Flow cytometry techniques in research activities 67 5.2.1.3 Use of flow cytometry in regenerative medicine 68 5.2.1.4 Growing public−private initiatives in immunology and immuno-oncology research 68 5.2.1.5 Technological advancements in flow cytometry instruments 69 TABLE 3 IMPORTANT TECHNOLOGICAL ADVANCEMENTS (2019–2022) 69 5.2.2 RESTRAINTS 70 5.2.2.1 High product cost 70 5.2.3 OPPORTUNITIES 71 5.2.3.1 Emerging markets 71 5.2.3.2 Public-private funding initiatives in stem cell research 71 TABLE 4 NIH-ESTIMATED STEM CELL RESEARCH EXPENDITURE DATA 72 5.2.3.3 Adoption of recombinant DNA technology for antibody production 72 5.2.4 CHALLENGES 72 5.2.4.1 Complexities related to reagent development 72 5.2.4.2 Shortage of well-trained and skilled professionals 73 5.3 PATENT ANALYSIS 73 5.3.1 LIST OF MAJOR PATENTS 74 5.4 SUPPLY CHAIN ANALYSIS 76 FIGURE 15 DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES 77 5.4.1 KEY INFLUENCERS 77 5.5 VALUE CHAIN ANALYSIS 78 FIGURE 16 FLOW CYTOMETRY MARKET: VALUE CHAIN ANALYSIS 78 5.6 ECOSYSTEM ANALYSIS 79 FIGURE 17 FLOW CYTOMETRY MARKET: ECOSYSTEM ANALYSIS 79 5.6.1 ROLE IN ECOSYSTEM 79 5.7 REGULATORY ASSESSMENT 80 5.7.1 STRINGENT FDA REQUIREMENTS 80 5.7.2 ANALYTE-SPECIFIC REAGENT RULE 80 5.7.3 LIMITATIONS IN VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS 80 5.7.4 ABSENCE OF TEST GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS 80 5.7.5 IVD CE MARK APPROVALS 81 5.7.6 US: REIMBURSEMENT SCENARIO 81 5.8 PORTER’S FIVE FORCES ANALYSIS 82 TABLE 5 FLOW CYTOMETRY MARKET- PORTER’S FIVE FORCES ANALYSIS 82 5.8.1 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 82 5.8.2 BARGAINING POWER OF SUPPLIERS 82 5.8.3 BARGAINING POWER OF BUYERS 83 5.8.4 THREAT OF SUBSTITUTES 83 5.8.5 THREAT OF NEW ENTRANTS 83 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 84 FIGURE 18 REVENUE SHIFT & NEW REVENUE POCKETS FOR FLOW CYTOMETRY MARKET 84 5.10 KEY CONFERENCES & EVENTS IN 2022-2023 84 TABLE 6 FLOW CYTOMETRY MARKET: DETAILED LIST OF EVENTS AND CONFERENCES 84 5.11 TRADE DATA 85 TABLE 7 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2017–2021 (USD THOUSAND) 85 TABLE 8 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2017–2021 (USD THOUSAND) 86 5.12 PRICING ANALYSIS 87 TABLE 9 COST OF FLOW CYTOMETERS, BY TYPE 87 TABLE 10 COST OF FLOW CYTOMETERS & OTHER PRODUCTS, BY COMPANY 87 5.12.1 COST OF FLOW CYTOMETRY SOFTWARE 87 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 88 FIGURE 19 KEY STAKEHOLDERS IN PHARMACEUTICAL COMPANIES AND INFLUENCES ON BUYING PROCESSES 88 FIGURE 20 KEY BUYING CRITERIA FOR FLOW CYTOMETRY PRODUCTS AMONG END USERS 88 6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY 89 6.1 INTRODUCTION 90 TABLE 11 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 90 6.2 CELL-BASED FLOW CYTOMETRY 90 6.2.1 RISING R&D INVESTMENTS FOR NEW THERAPEUTIC AGENTS TO DRIVE MARKET GROWTH 90 TABLE 12 CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2020–2027 (USD MILLION) 91 6.3 BEAD-BASED FLOW CYTOMETRY 91 6.3.1 HIGH RELIABILITY AND MEASUREMENT CONSISTENCIES OF BEAD-BASED FLOW CYTOMETRY TO SUPPORT GROWTH 91 TABLE 13 BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2020–2027 (USD MILLION) 92 7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE 93 7.1 INTRODUCTION 94 TABLE 14 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 94 7.2 REAGENTS & CONSUMABLES 94 7.2.1 INCREASING INVESTMENTS IN RESEARCH TO DRIVE MARKET DEMAND 94 TABLE 15 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION) 95 7.3 INSTRUMENTS 95 7.3.1 LAUNCH OF TECHNOLOGICALLY ADVANCED INSTRUMENTS TO PROPEL MARKET GROWTH 95 TABLE 16 FLOW CYTOMETRY INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION) 96 TABLE 17 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 96 7.3.2 CELL ANALYZERS 96 7.3.2.1 Investments by leading market players in developing cell analyzers to drive market growth 96 TABLE 18 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 97 TABLE 19 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY PRICE RANGE, 2020–2027 (USD MILLION) 97 7.3.2.2 High-range cell analyzers 98 7.3.2.2.1 Wide adoption of high-range cell analyzers among end users to drive market growth 98 TABLE 20 HIGH-RANGE CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 98 7.3.2.3 Mid-range cell analyzers 98 7.3.2.3.1 Availability of compact & high-performance analyzers to support market growth 98 TABLE 21 MID-RANGE CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 99 7.3.2.4 Low-range cell analyzers 99 7.3.2.4.1 Low-range analyzers significantly adopted among price-sensitive end users 99 TABLE 22 LOW-RANGE CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 99 7.3.3 CELL SORTERS 100 TABLE 23 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 100 TABLE 24 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY PRICE RANGE, 2020–2027 (USD MILLION) 101 7.3.3.1 High-range cell sorters 101 7.3.3.1.1 High cost and budgetary limitations to restrain market growth 101 TABLE 25 HIGH-RANGE CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 101 7.3.3.2 Mid-range cell sorters 102 7.3.3.2.1 Cost-efficiency & frequent product launches for mid-range sorters to drive market growth 102 TABLE 26 MID-RANGE CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 102 7.3.3.3 Low-range cell sorters 102 7.3.3.3.1 Small-scale labs and research facilities to be major end users of low-range sorters 102 TABLE 27 LOW-RANGE CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 103 7.4 SERVICES 103 7.4.1 FLOW CYTOMETRY SERVICES TO ENSURE WORKFLOW CONTINUITY AND MAXIMIZE PERFORMANCE 103 TABLE 28 FLOW CYTOMETRY SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 103 7.5 SOFTWARE 104 7.5.1 TECHNOLOGICAL ADVANCEMENTS IN SOFTWARE TO DRIVE MARKET GROWTH 104 TABLE 29 FLOW CYTOMETRY SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 104 7.6 ACCESSORIES 105 7.6.1 PROCEDURAL BENEFITS OFFERED BY FLOW CYTOMETRY ACCESSORIES TO SUPPORT MARKET GROWTH 105 TABLE 30 FLOW CYTOMETRY ACCESSORIES MARKET, BY REGION, 2020–2027 (USD MILLION) 105 8 FLOW CYTOMETRY MARKET, BY APPLICATION 106 8.1 INTRODUCTION 107 TABLE 31 FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 107 8.2 RESEARCH APPLICATIONS 107 TABLE 32 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 108 TABLE 33 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 108 8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY 108 TABLE 34 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 109 8.2.1.1 Drug discovery 109 8.2.1.1.1 Growing use of phenotypic cell-based assays in drug discovery to support market growth 109 TABLE 35 FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY REGION, 2020–2027 (USD MILLION) 110 8.2.1.2 Stem cell research 110 8.2.1.2.1 Increasing investments in stem cell research to drive demand for flow cytometry products 110 TABLE 36 FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY REGION, 2020–2027 (USD MILLION) 111 8.2.1.3 In vitro toxicity testing 111 8.2.1.3.1 Growing adoption of flow cytometry in drug discovery & development to support market growth 111 TABLE 37 FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY REGION, 2020–2027 (USD MILLION) 112 8.2.2 IMMUNOLOGY 112 8.2.2.1 Growing prevalence of infectious & autoimmune diseases to support market growth 112 TABLE 38 FLOW CYTOMETRY MARKET FOR IMMUNOLOGY, BY REGION, 2020–2027 (USD MILLION) 113 8.2.3 CELL SORTING 113 8.2.3.1 Technologically advanced cell sorters to drive market growth 113 TABLE 39 FLOW CYTOMETRY MARKET FOR CELL SORTING, BY REGION, 2020–2027 (USD MILLION) 114 8.2.4 APOPTOSIS 114 8.2.4.1 Growing use of apoptosis assays to support market growth 114 TABLE 40 FLOW CYTOMETRY MARKET FOR APOPTOSIS, BY REGION, 2020–2027 (USD MILLION) 114 8.2.5 CELL CYCLE ANALYSIS 115 8.2.5.1 Use of flowcytometry to detect chromosomal abnormalities 115 TABLE 41 FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS, BY REGION, 2020–2027 (USD MILLION) 115 8.2.6 CELL VIABILITY 115 8.2.6.1 Growing use of cell viability assays in research to support market growth 115 TABLE 42 FLOW CYTOMETRY MARKET FOR CELL VIABILITY, BY REGION, 2020–2027 (USD MILLION) 116 8.2.7 CELL COUNTING 116 8.2.7.1 Flow cytometry permits easy differentiation of cells via scattering or staining 116 TABLE 43 FLOW CYTOMETRY MARKET FOR CELL COUNTING, BY REGION, 2020–2027 (USD MILLION) 117 8.2.8 OTHER RESEARCH APPLICATIONS 117 TABLE 44 FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 117 8.3 CLINICAL APPLICATIONS 118 TABLE 45 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118 TABLE 46 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 118 8.3.1 CANCER 119 8.3.1.1 Growing use of flow cytometry techniques in cancer predictions to drive market growth 119 TABLE 47 ESTIMATED NUMBER OF NEW CANCER CASES (2020–2040) 119 TABLE 48 FLOW CYTOMETRY MARKET FOR CANCER, BY REGION, 2020–2027 (USD MILLION) 120 8.3.2 HEMATOLOGY 120 8.3.2.1 Increasing use of flow cytometry in hematology applications to drive market growth 120 TABLE 49 FLOW CYTOMETRY MARKET FOR HEMATOLOGY, BY REGION, 2020–2027 (USD MILLION) 120 8.4 IMMUNODEFICIENCY DISEASES 121 8.4.1 BENEFITS OF FLOW CYTOMETRY IN DIAGNOSIS OF IMMUNODEFICIENCY DISEASES TO DRIVE MARKET GROWTH 121 TABLE 50 APPLICATION OF FLOW CYTOMETRY IN DIAGNOSIS OF PRIMARY IMMUNODEFICIENCY DISEASES. 121 TABLE 51 FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASE, BY REGION, 2020–2027 (USD MILLION) 123 8.4.2 ORGAN & TISSUE TRANSPLANTATION 123 8.4.2.1 Increasing organ transplants worldwide to drive market growth 123 TABLE 52 FLOW CYTOMETRY MARKET FOR ORGAN TRANSPLANTATION, BY REGION, 2020–2027 (USD MILLION) 124 8.4.3 OTHER CLINICAL APPLICATIONS 124 TABLE 53 FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 124 8.5 INDUSTRIAL APPLICATIONS 125 8.5.1 GROWING USE OF FLOW CYTOMETRY TECHNIQUES IN FOOD & DIARY TO SUPPORT MARKET GROWTH 125 TABLE 54 FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 125 9 FLOW CYTOMETRY MARKET, BY END USER 126 9.1 INTRODUCTION 127 TABLE 55 FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 127 9.2 ACADEMIC & RESEARCH INSTITUTES 127 9.2.1 GROWING COLLABORATIONS AMONG ACADEMIC & RESEARCH INSTITUTES EXPECTED TO DRIVE MARKET 127 TABLE 56 FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION) 128 9.3 HOSPITALS & CLINICAL TESTING LABORATORIES 129 9.3.1 USE OF FLOW CYTOMETRY TECHNIQUES IN INFECTIOUS DISEASE DIAGNOSTICS TO DRIVE MARKET GROWTH 129 TABLE 57 FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 129 9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 130 9.4.1 INCREASING INVESTMENTS IN DRUG DISCOVERY & DEVELOPMENT TO SUPPORT MARKET GROWTH 130 TABLE 58 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION) 130 10 FLOW CYTOMETRY MARKET, BY REGION 131 10.1 INTRODUCTION 132 TABLE 59 FLOW CYTOMETRY MARKET, BY REGION, 2020–2027 (USD MILLION) 132 10.2 NORTH AMERICA 132 FIGURE 21 NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT 133 TABLE 60 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 133 TABLE 61 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 134 TABLE 62 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 134 TABLE 63 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134 TABLE 64 NORTH AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 135 TABLE 65 NORTH AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 135 TABLE 66 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 135 TABLE 67 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 136 TABLE 68 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 136 TABLE 69 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 137 TABLE 70 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 137 10.2.1 US 138 10.2.1.1 High incidence of cancer and HIV-AIDS to drive market growth 138 TABLE 71 US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 139 TABLE 72 US: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 139 TABLE 73 US: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 139 TABLE 74 US: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140 TABLE 75 US: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140 TABLE 76 US: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 140 TABLE 77 US: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 141 TABLE 78 US: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 141 TABLE 79 US: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 142 TABLE 80 US: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 142 10.2.2 CANADA 143 10.2.2.1 Ongoing government initiatives for life science research to drive demand 143 TABLE 81 CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 144 TABLE 82 CANADA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 144 TABLE 83 CANADA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 144 TABLE 84 CANADA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 145 TABLE 85 CANADA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 145 TABLE 86 CANADA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145 TABLE 87 CANADA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 146 TABLE 88 CANADA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 146 TABLE 89 CANADA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 147 TABLE 90 CANADA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 147 10.3 EUROPE 147 TABLE 91 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 148 TABLE 92 EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 148 TABLE 93 EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 149 TABLE 94 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 149 TABLE 95 EUROPE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 149 TABLE 96 EUROPE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 150 TABLE 97 EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150 TABLE 98 EUROPE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 151 TABLE 99 EUROPE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 151 TABLE 100 EUROPE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 152 TABLE 101 EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 152 10.3.1 GERMANY 153 10.3.1.1 Strong research & development infrastructure and awareness programs on flow cytometry to ensure market growth 153 TABLE 102 GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 153 TABLE 103 GERMANY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 154 TABLE 104 GERMANY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154 TABLE 105 GERMANY: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154 TABLE 106 GERMANY: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155 TABLE 107 GERMANY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 155 TABLE 108 GERMANY: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 156 TABLE 109 GERMANY: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 156 TABLE 110 GERMANY: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 157 TABLE 111 GERMANY: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 157 10.3.2 UK 157 10.3.2.1 Acceptance of flow cytometry products for clinical applications to propel market growth 157 TABLE 112 UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 158 TABLE 113 UK: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 159 TABLE 114 UK: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159 TABLE 115 UK: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159 TABLE 116 UK: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 160 TABLE 117 UK: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 160 TABLE 118 UK: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 161 TABLE 119 UK: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 161 TABLE 120 UK: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 162 TABLE 121 UK: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 162 10.3.3 FRANCE 162 10.3.3.1 Strong government funding for proteomics & genomics research to drive market growth 162 TABLE 122 FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 163 TABLE 123 FRANCE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 164 TABLE 124 FRANCE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 164 TABLE 125 FRANCE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 164 TABLE 126 FRANCE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 165 TABLE 127 FRANCE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165 TABLE 128 FRANCE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 166 TABLE 129 FRANCE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 166 TABLE 130 FRANCE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 167 TABLE 131 FRANCE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 167 10.3.4 ITALY 167 10.3.4.1 Rising geriatric population and increasing activities in life science to drive market growth 167 TABLE 132 ITALY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 168 TABLE 133 ITALY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 169 TABLE 134 ITALY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 169 TABLE 135 ITALY: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 169 TABLE 136 ITALY: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 170 TABLE 137 ITALY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 170 TABLE 138 ITALY: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 171 TABLE 139 ITALY: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 171 TABLE 140 ITALY: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 172 TABLE 141 ITALY: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 172 10.3.5 SPAIN 173 10.3.5.1 Growing focus on cancer diagnosis to drive demand 173 TABLE 142 SPAIN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 173 TABLE 143 SPAIN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 174 TABLE 144 SPAIN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 174 TABLE 145 SPAIN: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 174 TABLE 146 SPAIN: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 175 TABLE 147 SPAIN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 175 TABLE 148 SPAIN: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 176 TABLE 149 SPAIN: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 176 TABLE 150 SPAIN: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 177 TABLE 151 SPAIN: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 177 10.3.6 REST OF EUROPE (ROE) 177 TABLE 152 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 178 TABLE 153 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 178 TABLE 154 REST OF EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 179 TABLE 155 REST OF EUROPE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 179 TABLE 156 REST OF EUROPE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 179 TABLE 157 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 180 TABLE 158 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 180 TABLE 159 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 181 TABLE 160 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 181 TABLE 161 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 182
SummaryThe global flow cytometry market is projected to reach USD 6.9 billion by 2027 from USD 4.7 billion in 2022, at a CAGR of 8.1% during the forecast period. Rising prevalence of HIV/AIDS, cancer & autoimmune diseases across the globe is increasing adoption of flow cytometry for diagnosis hence projecting the market growth. Additionally, launch of technologically advent product is furthermore likely to propel the market growth during the forecast period of 2022-2027. Table of Contents1 INTRODUCTION 431.1 STUDY OBJECTIVES 43 1.2 MARKET DEFINITION 43 1.2.1 INCLUSIONS & EXCLUSIONS 44 1.3 STUDY SCOPE 44 1.3.1 MARKETS COVERED 44 1.3.2 YEARS CONSIDERED 45 1.4 CURRENCY CONSIDERED 45 1.5 LIMITATIONS 45 1.6 STAKEHOLDERS 46 1.7 SUMMARY OF CHANGES 46 2 RESEARCH METHODOLOGY 48 2.1 RESEARCH DATA 48 FIGURE 1 RESEARCH DESIGN 48 2.1.1 SECONDARY DATA 49 2.1.2 PRIMARY DATA 50 FIGURE 2 FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES 50 2.2 MARKET ESTIMATION METHODOLOGY 51 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 51 FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 52 FIGURE 4 AVERAGE MARKET SIZE ESTIMATION (2021) 52 2.3 DATA TRIANGULATION APPROACH 54 FIGURE 5 DATA TRIANGULATION METHODOLOGY 54 2.4 GROWTH FORECAST 55 2.5 LIMITATIONS 55 2.6 RISK ASSESSMENT 55 2.7 CAGR PROJECTIONS 56 2.7.1 SUPPLY-SIDE ANALYSIS 56 2.7.2 DEMAND-SIDE ANALYSIS 56 2.7.3 INSIGHTS FROM PRIMARY EXPERTS 57 3 EXECUTIVE SUMMARY 58 FIGURE 6 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION) 58 FIGURE 7 FLOW CYTOMETRY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 59 FIGURE 8 FLOW CYTOMETRY MARKET, BY END USER, 2021 59 FIGURE 9 GEOGRAPHICAL SNAPSHOT 60 4 PREMIUM INSIGHTS 61 4.1 FLOW CYTOMETRY MARKET OVERVIEW 61 FIGURE 10 INCREASING PREVALENCE OF AUTOIMMUNE DISEASES AND RISING ADVANCEMENTS IN FLOW CYTOMETRY TECHNIQUES DRIVE MARKET GROWTH 61 4.2 ASIA PACIFIC: FLOW CYTOMETRY MARKET SHARE, BY PRODUCT & SERVICE (2021) 62 FIGURE 11 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2021 62 4.3 FLOW CYTOMETRY MARKET SHARE, BY TECHNOLOGY, 2022 VS. 2027 63 FIGURE 12 CELL-BASED FLOW CYTOMETRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 63 4.4 FLOW CYTOMETRY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 64 FIGURE 13 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 64 5 MARKET OVERVIEW 65 5.1 INTRODUCTION 65 5.2 MARKET DYNAMICS 65 FIGURE 14 FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65 5.2.1 DRIVERS 66 5.2.1.1 Increasing incidence of HIV/AIDS and cancer 66 TABLE 1 INCIDENCE OF HIV/AIDS, BY REGION, 2020 66 TABLE 2 CANCER INCIDENCE, 2020 VS. 2040 66 5.2.1.2 Flow cytometry techniques in research activities 67 5.2.1.3 Use of flow cytometry in regenerative medicine 68 5.2.1.4 Growing public−private initiatives in immunology and immuno-oncology research 68 5.2.1.5 Technological advancements in flow cytometry instruments 69 TABLE 3 IMPORTANT TECHNOLOGICAL ADVANCEMENTS (2019–2022) 69 5.2.2 RESTRAINTS 70 5.2.2.1 High product cost 70 5.2.3 OPPORTUNITIES 71 5.2.3.1 Emerging markets 71 5.2.3.2 Public-private funding initiatives in stem cell research 71 TABLE 4 NIH-ESTIMATED STEM CELL RESEARCH EXPENDITURE DATA 72 5.2.3.3 Adoption of recombinant DNA technology for antibody production 72 5.2.4 CHALLENGES 72 5.2.4.1 Complexities related to reagent development 72 5.2.4.2 Shortage of well-trained and skilled professionals 73 5.3 PATENT ANALYSIS 73 5.3.1 LIST OF MAJOR PATENTS 74 5.4 SUPPLY CHAIN ANALYSIS 76 FIGURE 15 DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES 77 5.4.1 KEY INFLUENCERS 77 5.5 VALUE CHAIN ANALYSIS 78 FIGURE 16 FLOW CYTOMETRY MARKET: VALUE CHAIN ANALYSIS 78 5.6 ECOSYSTEM ANALYSIS 79 FIGURE 17 FLOW CYTOMETRY MARKET: ECOSYSTEM ANALYSIS 79 5.6.1 ROLE IN ECOSYSTEM 79 5.7 REGULATORY ASSESSMENT 80 5.7.1 STRINGENT FDA REQUIREMENTS 80 5.7.2 ANALYTE-SPECIFIC REAGENT RULE 80 5.7.3 LIMITATIONS IN VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS 80 5.7.4 ABSENCE OF TEST GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS 80 5.7.5 IVD CE MARK APPROVALS 81 5.7.6 US: REIMBURSEMENT SCENARIO 81 5.8 PORTER’S FIVE FORCES ANALYSIS 82 TABLE 5 FLOW CYTOMETRY MARKET- PORTER’S FIVE FORCES ANALYSIS 82 5.8.1 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 82 5.8.2 BARGAINING POWER OF SUPPLIERS 82 5.8.3 BARGAINING POWER OF BUYERS 83 5.8.4 THREAT OF SUBSTITUTES 83 5.8.5 THREAT OF NEW ENTRANTS 83 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 84 FIGURE 18 REVENUE SHIFT & NEW REVENUE POCKETS FOR FLOW CYTOMETRY MARKET 84 5.10 KEY CONFERENCES & EVENTS IN 2022-2023 84 TABLE 6 FLOW CYTOMETRY MARKET: DETAILED LIST OF EVENTS AND CONFERENCES 84 5.11 TRADE DATA 85 TABLE 7 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2017–2021 (USD THOUSAND) 85 TABLE 8 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2017–2021 (USD THOUSAND) 86 5.12 PRICING ANALYSIS 87 TABLE 9 COST OF FLOW CYTOMETERS, BY TYPE 87 TABLE 10 COST OF FLOW CYTOMETERS & OTHER PRODUCTS, BY COMPANY 87 5.12.1 COST OF FLOW CYTOMETRY SOFTWARE 87 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 88 FIGURE 19 KEY STAKEHOLDERS IN PHARMACEUTICAL COMPANIES AND INFLUENCES ON BUYING PROCESSES 88 FIGURE 20 KEY BUYING CRITERIA FOR FLOW CYTOMETRY PRODUCTS AMONG END USERS 88 6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY 89 6.1 INTRODUCTION 90 TABLE 11 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 90 6.2 CELL-BASED FLOW CYTOMETRY 90 6.2.1 RISING R&D INVESTMENTS FOR NEW THERAPEUTIC AGENTS TO DRIVE MARKET GROWTH 90 TABLE 12 CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2020–2027 (USD MILLION) 91 6.3 BEAD-BASED FLOW CYTOMETRY 91 6.3.1 HIGH RELIABILITY AND MEASUREMENT CONSISTENCIES OF BEAD-BASED FLOW CYTOMETRY TO SUPPORT GROWTH 91 TABLE 13 BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2020–2027 (USD MILLION) 92 7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE 93 7.1 INTRODUCTION 94 TABLE 14 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 94 7.2 REAGENTS & CONSUMABLES 94 7.2.1 INCREASING INVESTMENTS IN RESEARCH TO DRIVE MARKET DEMAND 94 TABLE 15 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION) 95 7.3 INSTRUMENTS 95 7.3.1 LAUNCH OF TECHNOLOGICALLY ADVANCED INSTRUMENTS TO PROPEL MARKET GROWTH 95 TABLE 16 FLOW CYTOMETRY INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION) 96 TABLE 17 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 96 7.3.2 CELL ANALYZERS 96 7.3.2.1 Investments by leading market players in developing cell analyzers to drive market growth 96 TABLE 18 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 97 TABLE 19 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY PRICE RANGE, 2020–2027 (USD MILLION) 97 7.3.2.2 High-range cell analyzers 98 7.3.2.2.1 Wide adoption of high-range cell analyzers among end users to drive market growth 98 TABLE 20 HIGH-RANGE CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 98 7.3.2.3 Mid-range cell analyzers 98 7.3.2.3.1 Availability of compact & high-performance analyzers to support market growth 98 TABLE 21 MID-RANGE CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 99 7.3.2.4 Low-range cell analyzers 99 7.3.2.4.1 Low-range analyzers significantly adopted among price-sensitive end users 99 TABLE 22 LOW-RANGE CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 99 7.3.3 CELL SORTERS 100 TABLE 23 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 100 TABLE 24 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY PRICE RANGE, 2020–2027 (USD MILLION) 101 7.3.3.1 High-range cell sorters 101 7.3.3.1.1 High cost and budgetary limitations to restrain market growth 101 TABLE 25 HIGH-RANGE CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 101 7.3.3.2 Mid-range cell sorters 102 7.3.3.2.1 Cost-efficiency & frequent product launches for mid-range sorters to drive market growth 102 TABLE 26 MID-RANGE CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 102 7.3.3.3 Low-range cell sorters 102 7.3.3.3.1 Small-scale labs and research facilities to be major end users of low-range sorters 102 TABLE 27 LOW-RANGE CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 103 7.4 SERVICES 103 7.4.1 FLOW CYTOMETRY SERVICES TO ENSURE WORKFLOW CONTINUITY AND MAXIMIZE PERFORMANCE 103 TABLE 28 FLOW CYTOMETRY SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 103 7.5 SOFTWARE 104 7.5.1 TECHNOLOGICAL ADVANCEMENTS IN SOFTWARE TO DRIVE MARKET GROWTH 104 TABLE 29 FLOW CYTOMETRY SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 104 7.6 ACCESSORIES 105 7.6.1 PROCEDURAL BENEFITS OFFERED BY FLOW CYTOMETRY ACCESSORIES TO SUPPORT MARKET GROWTH 105 TABLE 30 FLOW CYTOMETRY ACCESSORIES MARKET, BY REGION, 2020–2027 (USD MILLION) 105 8 FLOW CYTOMETRY MARKET, BY APPLICATION 106 8.1 INTRODUCTION 107 TABLE 31 FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 107 8.2 RESEARCH APPLICATIONS 107 TABLE 32 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 108 TABLE 33 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 108 8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY 108 TABLE 34 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2020–2027 (USD MILLION) 109 8.2.1.1 Drug discovery 109 8.2.1.1.1 Growing use of phenotypic cell-based assays in drug discovery to support market growth 109 TABLE 35 FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY REGION, 2020–2027 (USD MILLION) 110 8.2.1.2 Stem cell research 110 8.2.1.2.1 Increasing investments in stem cell research to drive demand for flow cytometry products 110 TABLE 36 FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY REGION, 2020–2027 (USD MILLION) 111 8.2.1.3 In vitro toxicity testing 111 8.2.1.3.1 Growing adoption of flow cytometry in drug discovery & development to support market growth 111 TABLE 37 FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY REGION, 2020–2027 (USD MILLION) 112 8.2.2 IMMUNOLOGY 112 8.2.2.1 Growing prevalence of infectious & autoimmune diseases to support market growth 112 TABLE 38 FLOW CYTOMETRY MARKET FOR IMMUNOLOGY, BY REGION, 2020–2027 (USD MILLION) 113 8.2.3 CELL SORTING 113 8.2.3.1 Technologically advanced cell sorters to drive market growth 113 TABLE 39 FLOW CYTOMETRY MARKET FOR CELL SORTING, BY REGION, 2020–2027 (USD MILLION) 114 8.2.4 APOPTOSIS 114 8.2.4.1 Growing use of apoptosis assays to support market growth 114 TABLE 40 FLOW CYTOMETRY MARKET FOR APOPTOSIS, BY REGION, 2020–2027 (USD MILLION) 114 8.2.5 CELL CYCLE ANALYSIS 115 8.2.5.1 Use of flowcytometry to detect chromosomal abnormalities 115 TABLE 41 FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS, BY REGION, 2020–2027 (USD MILLION) 115 8.2.6 CELL VIABILITY 115 8.2.6.1 Growing use of cell viability assays in research to support market growth 115 TABLE 42 FLOW CYTOMETRY MARKET FOR CELL VIABILITY, BY REGION, 2020–2027 (USD MILLION) 116 8.2.7 CELL COUNTING 116 8.2.7.1 Flow cytometry permits easy differentiation of cells via scattering or staining 116 TABLE 43 FLOW CYTOMETRY MARKET FOR CELL COUNTING, BY REGION, 2020–2027 (USD MILLION) 117 8.2.8 OTHER RESEARCH APPLICATIONS 117 TABLE 44 FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 117 8.3 CLINICAL APPLICATIONS 118 TABLE 45 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118 TABLE 46 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 118 8.3.1 CANCER 119 8.3.1.1 Growing use of flow cytometry techniques in cancer predictions to drive market growth 119 TABLE 47 ESTIMATED NUMBER OF NEW CANCER CASES (2020–2040) 119 TABLE 48 FLOW CYTOMETRY MARKET FOR CANCER, BY REGION, 2020–2027 (USD MILLION) 120 8.3.2 HEMATOLOGY 120 8.3.2.1 Increasing use of flow cytometry in hematology applications to drive market growth 120 TABLE 49 FLOW CYTOMETRY MARKET FOR HEMATOLOGY, BY REGION, 2020–2027 (USD MILLION) 120 8.4 IMMUNODEFICIENCY DISEASES 121 8.4.1 BENEFITS OF FLOW CYTOMETRY IN DIAGNOSIS OF IMMUNODEFICIENCY DISEASES TO DRIVE MARKET GROWTH 121 TABLE 50 APPLICATION OF FLOW CYTOMETRY IN DIAGNOSIS OF PRIMARY IMMUNODEFICIENCY DISEASES. 121 TABLE 51 FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASE, BY REGION, 2020–2027 (USD MILLION) 123 8.4.2 ORGAN & TISSUE TRANSPLANTATION 123 8.4.2.1 Increasing organ transplants worldwide to drive market growth 123 TABLE 52 FLOW CYTOMETRY MARKET FOR ORGAN TRANSPLANTATION, BY REGION, 2020–2027 (USD MILLION) 124 8.4.3 OTHER CLINICAL APPLICATIONS 124 TABLE 53 FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 124 8.5 INDUSTRIAL APPLICATIONS 125 8.5.1 GROWING USE OF FLOW CYTOMETRY TECHNIQUES IN FOOD & DIARY TO SUPPORT MARKET GROWTH 125 TABLE 54 FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 125 9 FLOW CYTOMETRY MARKET, BY END USER 126 9.1 INTRODUCTION 127 TABLE 55 FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 127 9.2 ACADEMIC & RESEARCH INSTITUTES 127 9.2.1 GROWING COLLABORATIONS AMONG ACADEMIC & RESEARCH INSTITUTES EXPECTED TO DRIVE MARKET 127 TABLE 56 FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION) 128 9.3 HOSPITALS & CLINICAL TESTING LABORATORIES 129 9.3.1 USE OF FLOW CYTOMETRY TECHNIQUES IN INFECTIOUS DISEASE DIAGNOSTICS TO DRIVE MARKET GROWTH 129 TABLE 57 FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 129 9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 130 9.4.1 INCREASING INVESTMENTS IN DRUG DISCOVERY & DEVELOPMENT TO SUPPORT MARKET GROWTH 130 TABLE 58 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION) 130 10 FLOW CYTOMETRY MARKET, BY REGION 131 10.1 INTRODUCTION 132 TABLE 59 FLOW CYTOMETRY MARKET, BY REGION, 2020–2027 (USD MILLION) 132 10.2 NORTH AMERICA 132 FIGURE 21 NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT 133 TABLE 60 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 133 TABLE 61 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 134 TABLE 62 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 134 TABLE 63 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134 TABLE 64 NORTH AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 135 TABLE 65 NORTH AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 135 TABLE 66 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 135 TABLE 67 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 136 TABLE 68 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 136 TABLE 69 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 137 TABLE 70 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 137 10.2.1 US 138 10.2.1.1 High incidence of cancer and HIV-AIDS to drive market growth 138 TABLE 71 US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 139 TABLE 72 US: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 139 TABLE 73 US: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 139 TABLE 74 US: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140 TABLE 75 US: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140 TABLE 76 US: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 140 TABLE 77 US: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 141 TABLE 78 US: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 141 TABLE 79 US: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 142 TABLE 80 US: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 142 10.2.2 CANADA 143 10.2.2.1 Ongoing government initiatives for life science research to drive demand 143 TABLE 81 CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 144 TABLE 82 CANADA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 144 TABLE 83 CANADA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 144 TABLE 84 CANADA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 145 TABLE 85 CANADA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 145 TABLE 86 CANADA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145 TABLE 87 CANADA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 146 TABLE 88 CANADA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 146 TABLE 89 CANADA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 147 TABLE 90 CANADA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 147 10.3 EUROPE 147 TABLE 91 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 148 TABLE 92 EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 148 TABLE 93 EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 149 TABLE 94 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 149 TABLE 95 EUROPE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 149 TABLE 96 EUROPE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 150 TABLE 97 EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150 TABLE 98 EUROPE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 151 TABLE 99 EUROPE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 151 TABLE 100 EUROPE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 152 TABLE 101 EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 152 10.3.1 GERMANY 153 10.3.1.1 Strong research & development infrastructure and awareness programs on flow cytometry to ensure market growth 153 TABLE 102 GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 153 TABLE 103 GERMANY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 154 TABLE 104 GERMANY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154 TABLE 105 GERMANY: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154 TABLE 106 GERMANY: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155 TABLE 107 GERMANY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 155 TABLE 108 GERMANY: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 156 TABLE 109 GERMANY: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 156 TABLE 110 GERMANY: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 157 TABLE 111 GERMANY: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 157 10.3.2 UK 157 10.3.2.1 Acceptance of flow cytometry products for clinical applications to propel market growth 157 TABLE 112 UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 158 TABLE 113 UK: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 159 TABLE 114 UK: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159 TABLE 115 UK: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159 TABLE 116 UK: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 160 TABLE 117 UK: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 160 TABLE 118 UK: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 161 TABLE 119 UK: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 161 TABLE 120 UK: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 162 TABLE 121 UK: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 162 10.3.3 FRANCE 162 10.3.3.1 Strong government funding for proteomics & genomics research to drive market growth 162 TABLE 122 FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 163 TABLE 123 FRANCE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 164 TABLE 124 FRANCE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 164 TABLE 125 FRANCE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 164 TABLE 126 FRANCE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 165 TABLE 127 FRANCE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165 TABLE 128 FRANCE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 166 TABLE 129 FRANCE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 166 TABLE 130 FRANCE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 167 TABLE 131 FRANCE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 167 10.3.4 ITALY 167 10.3.4.1 Rising geriatric population and increasing activities in life science to drive market growth 167 TABLE 132 ITALY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 168 TABLE 133 ITALY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 169 TABLE 134 ITALY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 169 TABLE 135 ITALY: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 169 TABLE 136 ITALY: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 170 TABLE 137 ITALY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 170 TABLE 138 ITALY: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 171 TABLE 139 ITALY: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 171 TABLE 140 ITALY: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 172 TABLE 141 ITALY: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 172 10.3.5 SPAIN 173 10.3.5.1 Growing focus on cancer diagnosis to drive demand 173 TABLE 142 SPAIN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 173 TABLE 143 SPAIN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 174 TABLE 144 SPAIN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 174 TABLE 145 SPAIN: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 174 TABLE 146 SPAIN: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 175 TABLE 147 SPAIN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 175 TABLE 148 SPAIN: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 176 TABLE 149 SPAIN: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 176 TABLE 150 SPAIN: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 177 TABLE 151 SPAIN: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 177 10.3.6 REST OF EUROPE (ROE) 177 TABLE 152 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 178 TABLE 153 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 178 TABLE 154 REST OF EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 179 TABLE 155 REST OF EUROPE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 179 TABLE 156 REST OF EUROPE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 179 TABLE 157 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 180 TABLE 158 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 180 TABLE 159 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 181 TABLE 160 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 181 TABLE 161 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 182
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(非耐久財)の最新刊レポート
MarketsandMarkets社の非耐久財分野での最新刊レポート
本レポートと同じKEY WORD(cytometry)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |